{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus du SRAS : Questions médicales les plus fréquentes",
"headline": "Virus du SRAS : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus du SRAS : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2026-02-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus du SRAS"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Betacoronavirus",
"url": "https://questionsmedicales.fr/mesh/D000073640",
"about": {
"@type": "MedicalCondition",
"name": "Betacoronavirus",
"code": {
"@type": "MedicalCode",
"code": "D000073640",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.500.540.150.113"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "SARS-CoV-2",
"alternateName": "SARS-CoV-2",
"url": "https://questionsmedicales.fr/mesh/D000086402",
"about": {
"@type": "MedicalCondition",
"name": "SARS-CoV-2",
"code": {
"@type": "MedicalCode",
"code": "D000086402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.500.540.150.113.937.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virus du SRAS",
"alternateName": "Severe acute respiratory syndrome-related coronavirus",
"code": {
"@type": "MedicalCode",
"code": "D045473",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Matthew P Cheng",
"url": "https://questionsmedicales.fr/author/Matthew%20P%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "McGill University Health Centre and McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada (M.P.C.)."
}
},
{
"@type": "Person",
"name": "Cedric P Yansouni",
"url": "https://questionsmedicales.fr/author/Cedric%20P%20Yansouni",
"affiliation": {
"@type": "Organization",
"name": "McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.)."
}
},
{
"@type": "Person",
"name": "Michaël Desjardins",
"url": "https://questionsmedicales.fr/author/Micha%C3%ABl%20Desjardins",
"affiliation": {
"@type": "Organization",
"name": "Brigham and Women's Hospital, Boston, Massachusetts, and Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada (M.D.)."
}
},
{
"@type": "Person",
"name": "Sanjat Kanjilal",
"url": "https://questionsmedicales.fr/author/Sanjat%20Kanjilal",
"affiliation": {
"@type": "Organization",
"name": "Brigham and Women's Hospital and Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, Massachusetts (S.K.)."
}
},
{
"@type": "Person",
"name": "Caroline Quach",
"url": "https://questionsmedicales.fr/author/Caroline%20Quach",
"affiliation": {
"@type": "Organization",
"name": "CHU Sainte-Justine, Université de Montréal, Montreal, Canada (C.Q.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses.",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37832946",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1146/annurev-pathol-052620-121224"
}
},
{
"@type": "ScholarlyArticle",
"name": "Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36866737",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCP.0000000000000947"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.",
"datePublished": "2024-04-13",
"url": "https://questionsmedicales.fr/article/38615394",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mib.2024.102474"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cardiac damage and tropism of severe acute respiratory syndrome coronavirus 2.",
"datePublished": "2024-02-23",
"url": "https://questionsmedicales.fr/article/38394964",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mib.2024.102437"
}
},
{
"@type": "ScholarlyArticle",
"name": "Seizures in Children With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38924826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pediatrneurol.2024.05.023"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN à brin positif",
"item": "https://questionsmedicales.fr/mesh/D000085102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nidovirales",
"item": "https://questionsmedicales.fr/mesh/D028381"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coronaviridae",
"item": "https://questionsmedicales.fr/mesh/D003332"
},
{
"@type": "ListItem",
"position": 7,
"name": "Coronavirus",
"item": "https://questionsmedicales.fr/mesh/D017934"
},
{
"@type": "ListItem",
"position": 8,
"name": "Betacoronavirus",
"item": "https://questionsmedicales.fr/mesh/D000073640"
},
{
"@type": "ListItem",
"position": 9,
"name": "Virus du SRAS",
"item": "https://questionsmedicales.fr/mesh/D045473"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus du SRAS - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus du SRAS",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus du SRAS",
"description": "Comment le SRAS est-il diagnostiqué ?\nQuels tests sont utilisés pour le SRAS ?\nLe SRAS peut-il être confondu avec d'autres maladies ?\nQuels symptômes indiquent un test pour le SRAS ?\nLes radiographies sont-elles utiles pour le SRAS ?",
"url": "https://questionsmedicales.fr/mesh/D045473#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus du SRAS",
"description": "Quels sont les symptômes courants du SRAS ?\nLe SRAS provoque-t-il des complications respiratoires ?\nLes symptômes du SRAS apparaissent-ils rapidement ?\nY a-t-il des symptômes gastro-intestinaux associés ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D045473#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus du SRAS",
"description": "Comment prévenir la transmission du SRAS ?\nLes vaccins contre le SRAS existent-ils ?\nQuelles mesures de quarantaine sont recommandées ?\nLes voyages vers des zones à risque doivent-ils être évités ?\nLes établissements de santé doivent-ils être préparés ?",
"url": "https://questionsmedicales.fr/mesh/D045473#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus du SRAS",
"description": "Quel est le traitement principal du SRAS ?\nLes antibiotiques sont-ils efficaces contre le SRAS ?\nLe traitement préventif est-il disponible pour le SRAS ?\nLes corticostéroïdes sont-ils utilisés pour le SRAS ?\nLe soutien respiratoire est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D045473#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus du SRAS",
"description": "Quelles sont les complications possibles du SRAS ?\nLe SRAS peut-il entraîner des séquelles à long terme ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nLe SRAS peut-il causer des problèmes cardiaques ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D045473#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus du SRAS",
"description": "Qui est le plus à risque de développer le SRAS ?\nLes travailleurs de la santé sont-ils plus exposés ?\nLes voyages dans des zones à risque augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLe contact avec des animaux infectés est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D045473#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le SRAS est-il diagnostiqué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, des cultures virales et des analyses sérologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le SRAS ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les tests sérologiques sont couramment utilisés pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il être confondu avec d'autres maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec la grippe ou d'autres infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test pour le SRAS ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, dyspnée et antécédents de voyage dans des zones à risque sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Les radiographies sont-elles utiles pour le SRAS ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les radiographies thoraciques peuvent montrer des infiltrats pulmonaires caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du SRAS ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux sèche, essoufflement, douleurs musculaires et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Le SRAS provoque-t-il des complications respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner une pneumonie et une détresse respiratoire aiguë."
}
},
{
"@type": "Question",
"name": "Les symptômes du SRAS apparaissent-ils rapidement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes apparaissent généralement 2 à 7 jours après l'exposition au virus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes gastro-intestinaux associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des diarrhées ou des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir la transmission du SRAS ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le lavage des mains, le port de masques et l'évitement des contacts étroits sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins contre le SRAS existent-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre le SRAS."
}
},
{
"@type": "Question",
"name": "Quelles mesures de quarantaine sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes exposées doivent être mises en quarantaine pour éviter la propagation."
}
},
{
"@type": "Question",
"name": "Les voyages vers des zones à risque doivent-ils être évités ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé d'éviter les voyages vers des zones où le SRAS est actif."
}
},
{
"@type": "Question",
"name": "Les établissements de santé doivent-ils être préparés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hôpitaux doivent avoir des protocoles pour gérer les cas suspects de SRAS."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du SRAS ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique, le soutien respiratoire est essentiel."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le SRAS ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car le SRAS est causé par un virus."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il disponible pour le SRAS ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun traitement préventif spécifique n'est disponible, la prévention repose sur l'hygiène."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés pour le SRAS ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent être utilisés pour réduire l'inflammation dans certains cas."
}
},
{
"@type": "Question",
"name": "Le soutien respiratoire est-il crucial ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien respiratoire est vital pour les patients présentant une détresse respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du SRAS ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, l'insuffisance respiratoire et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des séquelles respiratoires persistantes après guérison."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et celles avec des comorbidités sont plus à risque."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il causer des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le SRAS peut affecter le cœur, entraînant des complications cardiaques."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cas de complications neurologiques ont été rapportés chez certains patients atteints de SRAS."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de développer le SRAS ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils plus exposés ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé sont à risque accru en raison de leur exposition aux patients."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones à risque augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le SRAS est présent augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ont un risque accru de développer des formes graves de la maladie."
}
},
{
"@type": "Question",
"name": "Le contact avec des animaux infectés est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec des animaux porteurs du virus peut augmenter le risque d'infection."
}
}
]
}
]
}
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
Foundation of Innovative New Diagnostics (FIND), Geneva, Switzerland, and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom (S.D.).
McGill Interdisciplinary Initiative in Infection and Immunity, School of Population and Global Health, McGill University, and Montreal Children's Hospital, Montreal, Quebec, Canada (J.P.).
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
Over the last two decades the world has witnessed the global spread of two genetically related highly pathogenic coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2....
The coronavirus disease 2019 pandemic has had a wide-ranging and profound impact on how we think about the transmission of respiratory viruses This review outlines the basis on which we should conside...
We present recent studies to support the aerosol transmission of severe acute respiratory syndrome coronavirus 2, and some older studies to demonstrate the aerosol transmissibility of other, more fami...
Current knowledge on how these respiratory viruses are transmitted, and the way we control their spread, is changing. We need to embrace these changes to improve the care of patients in hospitals and ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019, contributes to neurological pathologies in nearly 30% of patients, extending beyond respi...
Until now, the World Health Organization registered over 771 million cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection worldwide, of which 6.97 million resulted in death....
Although respiratory symptoms are the most prominent manifestations of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and especially the omicron var...
This was a retrospective multicenter study of pediatric (zero to 16 years) patients with COVID-19 who attended five pediatric emergency departments in Madrid, Spain, between March 2020 and July 2022. ...
A total of 2411 seizures (infectious and noninfectious) were recorded, and 35 of them (1.4%) were positive for SARS-CoV-2. Of those 35 patients, 18 (51.4%) reported a history of previous seizures. The...
during the emergence of the omicron variant, there has been an increase in the number of COVID-19-associated seizures. These findings highlight the need for SARS-CoV-2 screening in patients with febri...
The continued pressure of COVID-19 on public health worldwide underlines the need for a better understanding of the mechanisms of disease caused by severe acute respiratory syndrome coronavirus-2. Tho...
Repurposing vitamins as antiviral supporting agents is a rapid approach used to control emerging viral infections. Although there is considerable evidence supporting the use of vitamin supplementation...
Endothelial cell (EC) dysfunction is a characteristic complication of coronavirus-19 (COVID-19). This review discusses the role of the endothelium during the pathogenesis of severe acute respiratory s...
In the coronavirus disease 2019 (COVID-19) pandemic, correctional facilities are potential hotspots for transmission. We examined the genomic epidemiology of severe acute respiratory syndrome coronavi...
Existing SARS-CoV-2 isolates from 131 detainees at the Cook County Jail in Chicago, Illinois, from March 2020 through May 2020 were analyzed by whole-genome sequencing. Contemporaneous isolates from R...
We identified 29 jail-only clusters that contained 75 of the 132 SARS-CoV-2 isolates from detainees; of these clusters, 17 (58.6%) had individuals who overlapped in the jail during putative transmissi...
Our findings suggest that there was transmission of SARS-CoV-2 in the jail, in the setting of extensive importation of COVID-19 from the community. Numerous infection control practices at intake and d...
The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during the endemic phase may vary from that during the previous pandemic phase. We evaluated the risk of infection...
This study included 1,286 individuals who had been in contact with an index COVID-19 case between January 24, 2020, and June 30, 2022. Variables such as age, sex, nationality, place of contact, level ...
Among 1,286 participants, 132 (10.30%) were confirmed to have COVID-19. With increasing age, the risk of the exposed persons contracting COVID-19 from index cases tended to increase (...
The risk of COVID-19 transmission is high in long-term care facilities where many older adults reside. Intensive management of facilities at risk of infection and strict mask-wearing of confirmed COVI...